Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|June 27, 2023
HR+/HER2- Advanced Breast Cancer Treatment in the First-Line Setting: Expert ReviewKatarzyna J Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, et al.Current Oncology (Toronto, Ont.)|August 27, 2025
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in CanadaKatarzyna J Jerzak, Sandeep Sehdev, Jean-François Boileau, et al.Current Oncology (Toronto, Ont.)|June 25, 2025
Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to ActionEvan Weber, Carlos A Carmona-Gonzalez, Melanie Boucher, et al.Journal of Bone Oncology|March 8, 2021
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalationSharon McGee, Mashari AlZahrani, Carol Stober, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2021
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient surveyMashari Alzahrani, Mark Clemons, Marta Sienkiewicz, et al.Ecancermedicalscience|January 21, 2026
Bridging gaps in breast cancer care: a Breast Cancer Care Quality Index to improve outcomes worldwideEduardo Cazap, Benjamin O Anderson, Giuseppe Curigliano, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2025
Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidanceKim A Papp, Luis Puig, Jennifer Beecker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trialWolfgang Eiermann, Tadeusz Pienkowski, John Crown, et al.Journal of Evaluation in Clinical Practice|January 24, 2019
Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trialSusan J Robertson, Mohammed F K Ibrahim, Carol Stober, et al.Current Oncology (Toronto, Ont.)|May 24, 2024
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High PricesDavid J Stewart, John-Peter Bradford, Sandeep Sehdev, et al.Pageof 4